DHR
Price
$208.24
Change
-$0.82 (-0.39%)
Updated
Oct 20, 04:59 PM (EDT)
Capitalization
149.22B
One day until earnings call
Intraday Buy/Sell Signals
WAT
Price
$343.08
Change
+$8.49 (+2.54%)
Updated
Oct 20, 04:59 PM (EDT)
Capitalization
20.43B
15 days until earnings call
Intraday Buy/Sell Signals
Interact to see
Advertisement

DHR vs WAT

Header iconDHR vs WAT Comparison
Open Charts DHR vs WATBanner chart's image
Danaher
Price$208.24
Change-$0.82 (-0.39%)
Volume$34.92K
Capitalization149.22B
Waters
Price$343.08
Change+$8.49 (+2.54%)
Volume$3K
Capitalization20.43B
DHR vs WAT Comparison Chart in %
DHR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
WAT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DHR vs. WAT commentary
Oct 21, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DHR is a Hold and WAT is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 21, 2025
Stock price -- (DHR: $209.06 vs. WAT: $334.59)
Brand notoriety: DHR and WAT are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: DHR: 102% vs. WAT: 67%
Market capitalization -- DHR: $149.22B vs. WAT: $20.43B
DHR [@Medical Specialties] is valued at $149.22B. WAT’s [@Medical Specialties] market capitalization is $20.43B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $11.58B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DHR’s FA Score shows that 1 FA rating(s) are green whileWAT’s FA Score has 1 green FA rating(s).

  • DHR’s FA Score: 1 green, 4 red.
  • WAT’s FA Score: 1 green, 4 red.
According to our system of comparison, both DHR and WAT are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DHR’s TA Score shows that 4 TA indicator(s) are bullish while WAT’s TA Score has 6 bullish TA indicator(s).

  • DHR’s TA Score: 4 bullish, 6 bearish.
  • WAT’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, WAT is a better buy in the short-term than DHR.

Price Growth

DHR (@Medical Specialties) experienced а +3.26% price change this week, while WAT (@Medical Specialties) price change was +1.08% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +2.66%. For the same industry, the average monthly price growth was +5.12%, and the average quarterly price growth was +51.03%.

Reported Earning Dates

DHR is expected to report earnings on Oct 21, 2025.

WAT is expected to report earnings on Nov 04, 2025.

Industries' Descriptions

@Medical Specialties (+2.66% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DHR($149B) has a higher market cap than WAT($20.4B). DHR has higher P/E ratio than WAT: DHR (44.24) vs WAT (30.94). DHR YTD gains are higher at: -8.481 vs. WAT (-9.809). DHR has higher annual earnings (EBITDA): 6.76B vs. WAT (1.06B). WAT has less debt than DHR: WAT (1.54B) vs DHR (17.4B). DHR has higher revenues than WAT: DHR (24B) vs WAT (3.05B).
DHRWATDHR / WAT
Capitalization149B20.4B730%
EBITDA6.76B1.06B639%
Gain YTD-8.481-9.80986%
P/E Ratio44.2430.94143%
Revenue24B3.05B788%
Total CashN/A367M-
Total Debt17.4B1.54B1,131%
FUNDAMENTALS RATINGS
DHR vs WAT: Fundamental Ratings
DHR
WAT
OUTLOOK RATING
1..100
7032
VALUATION
overvalued / fair valued / undervalued
1..100
22
Undervalued
87
Overvalued
PROFIT vs RISK RATING
1..100
7854
SMR RATING
1..100
8025
PRICE GROWTH RATING
1..100
5048
P/E GROWTH RATING
1..100
5470
SEASONALITY SCORE
1..100
5085

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

DHR's Valuation (22) in the Medical Specialties industry is somewhat better than the same rating for WAT (87). This means that DHR’s stock grew somewhat faster than WAT’s over the last 12 months.

WAT's Profit vs Risk Rating (54) in the Medical Specialties industry is in the same range as DHR (78). This means that WAT’s stock grew similarly to DHR’s over the last 12 months.

WAT's SMR Rating (25) in the Medical Specialties industry is somewhat better than the same rating for DHR (80). This means that WAT’s stock grew somewhat faster than DHR’s over the last 12 months.

WAT's Price Growth Rating (48) in the Medical Specialties industry is in the same range as DHR (50). This means that WAT’s stock grew similarly to DHR’s over the last 12 months.

DHR's P/E Growth Rating (54) in the Medical Specialties industry is in the same range as WAT (70). This means that DHR’s stock grew similarly to WAT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
DHRWAT
RSI
ODDS (%)
Bearish Trend 4 days ago
58%
Bearish Trend 4 days ago
46%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
64%
Bearish Trend 4 days ago
62%
Momentum
ODDS (%)
Bearish Trend 4 days ago
60%
Bullish Trend 4 days ago
68%
MACD
ODDS (%)
Bullish Trend 4 days ago
66%
Bullish Trend 4 days ago
72%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
57%
Bullish Trend 4 days ago
68%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
55%
Bullish Trend 4 days ago
64%
Advances
ODDS (%)
Bullish Trend 7 days ago
53%
Bullish Trend 8 days ago
66%
Declines
ODDS (%)
Bearish Trend 11 days ago
61%
Bearish Trend 6 days ago
59%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
59%
Bearish Trend 4 days ago
57%
Aroon
ODDS (%)
Bearish Trend 4 days ago
55%
Bullish Trend 4 days ago
65%
View a ticker or compare two or three
Interact to see
Advertisement
DHR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
WAT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
EWZS13.170.15
+1.17%
iShares MSCI Brazil Small-Cap ETF
DVND34.63N/A
N/A
Touchstone Dividend Select ETF
EEM54.18-0.01
-0.02%
iShares MSCI Emerging Markets ETF
YFFI10.27-0.03
-0.25%
Indexperts Yield Focused Fxd Inc ETF
NIE25.27-0.07
-0.28%
Virtus Equity & Convertible Income Fund